Welcome to LookChem.com Sign In|Join Free
  • or
2,6-DIMETHYLIMIDAZO[2,1-B]THIAZOLE-5-CARBOXYLIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1007875-19-5

Post Buying Request

1007875-19-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1007875-19-5 Usage

Class

Imidazo thiazoles

Functional group

Carboxylic acid

Use in industry

Building block for the synthesis of biologically active molecules

Applications

Development of drugs and agrochemicals

Diverse activities

Pharmacological and biological

Molecular structure

Unique, valuable intermediate in organic chemistry for the creation of compounds with therapeutic properties.

Check Digit Verification of cas no

The CAS Registry Mumber 1007875-19-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,8,7 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1007875-19:
(9*1)+(8*0)+(7*0)+(6*7)+(5*8)+(4*7)+(3*5)+(2*1)+(1*9)=145
145 % 10 = 5
So 1007875-19-5 is a valid CAS Registry Number.

1007875-19-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dimethylimidazo[2,1-b]thiazole-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2,6-dimethyl-imidazo[2,1-b]thiazole-5-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1007875-19-5 SDS

1007875-19-5Downstream Products

1007875-19-5Relevant academic research and scientific papers

Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis

Lu, Xiaoyun,Tang, Jian,Liu, Zhiyong,Li, Minke,Zhang, Tianyu,Zhang, Xiantao,Ding, Ke

, p. 5916 - 5919 (2016)

A series of biheterocyclic (1H-indole, benzofuran, pyrazolo[1,5-a]pyrimidine, pyrazolo[1,5-a]pyrimidin-5(4H)-one, imidazo[2,1-b]thiazole and pyrazolo[5,1-b]thiazole) derivatives were synthesized and evaluated for their anti-tubercular activities. The imid

BENZYL AMINE-CONTAINING HETEROCYCLIC COMPOUNDS AND COMPOSITIONS USEFUL AGAINST MYCOBACTERIAL INFECTION

-

Page/Page column 49, (2017/04/11)

Described herein are compounds and compositions, and methods of making and their use as effective agents against mycobacterial infections.

5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS

-

Paragraph 0216; 0237; 0238; 0246; 0256, (2016/10/10)

The invention provides a series of 5,5-heteroaromatic compounds, syntheses thereof, compositions thereof, and methods of using such compounds and compositions. Various embodiments provide methods of killing and/or inhibiting the growth of M. tuberculosis

5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS

-

Paragraph 0167, (2015/08/04)

The invention provides a series of 5,5-heteroaromatic compounds, syntheses thereof, compositions thereof, and methods of using such compounds and compositions. Various embodiments provide methods of killing and/or inhibiting the growth of M. tuberculosis

3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES

-

Page/Page column 45, (2010/02/17)

The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.

TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES

-

Page/Page column 81, (2009/03/07)

The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1007875-19-5